• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型遗传性酪氨酸血症:人延胡索酰乙酰乙酸水解酶基因中的新型错义、无义及剪接共有序列突变;基因型-表型关系的变异性

Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.

作者信息

Ploos van Amstel J K, Bergman A J, van Beurden E A, Roijers J F, Peelen T, van den Berg I E, Poll-The B T, Kvittingen E A, Berger R

机构信息

DNA Laboratory, Clinical Genetics Center, Utrecht, The Netherlands.

出版信息

Hum Genet. 1996 Jan;97(1):51-9. doi: 10.1007/BF00218833.

DOI:10.1007/BF00218833
PMID:8557261
Abstract

The complete fumarylacetoacetate hydrolase (FAH) genotype of probands of thirteen unrelated families with hereditary tyrosinemia type 1 (HT 1) was established. The screening was performed by analysis of exons 2-14 of the FAH gene by using the polymerase chain reaction (PCR) and of the mRNA by reverse transcription/PCR. Nine different mutations were identified, of which six are novel. Three mutations involve consensus sequences for correct splicing, viz. IVS 6-1 (g-t), IVS 7-1 (g-a) and IVS 12 + 5 (g-a). Two missense mutations (C193R and G369V) and three nonsense mutations (R237X, E357X and E364X) were found. One silent mutation N232N was associated with the skipping of exon 8 from the FAH mRNA. Analysis of the effect of the respective mutations on the FAH mRNA showed a strong reduction of FAH mRNA levels in association with the nonsense mutations, and normal levels with the missense mutations. The splice consensus mutations give deletions of complete or small parts of exon sequences from the FAH mRNA. Data suggest a founder effect for several of the mutations, with a frequency for both the IVS 6-1 (g-t) and IVS 12 + 5 (g-a) mutations of approximately 30% in the HT 1 probands. No strict correlation between genotype and phenotype, i.e. the acute, subacute or chronic form of HT 1, was evident.

摘要

确定了13个无关家族的遗传性1型酪氨酸血症(HT 1)先证者的完整富马酰乙酰乙酸水解酶(FAH)基因型。通过使用聚合酶链反应(PCR)分析FAH基因的外显子2 - 14以及通过逆转录/PCR分析mRNA来进行筛查。鉴定出9种不同的突变,其中6种是新的。三种突变涉及正确剪接的共有序列,即内含子6 - 1(g - t)、内含子7 - 1(g - a)和内含子12 + 5(g - a)。发现了两个错义突变(C193R和G369V)和三个无义突变(R237X、E357X和E364X)。一个沉默突变N232N与FAH mRNA中外显子8的跳跃有关。对各个突变对FAH mRNA影响的分析表明,与无义突变相关的FAH mRNA水平大幅降低,而与错义突变相关的FAH mRNA水平正常。剪接共有序列突变导致FAH mRNA中外显子序列的全部或部分缺失。数据表明几种突变存在奠基者效应,在HT 1先证者中,内含子6 - 1(g - t)和内含子12 + 5(g - a)突变的频率约为30%。基因型与表型(即HT 1的急性、亚急性或慢性形式)之间没有明显的严格相关性。

相似文献

1
Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.1型遗传性酪氨酸血症:人延胡索酰乙酰乙酸水解酶基因中的新型错义、无义及剪接共有序列突变;基因型-表型关系的变异性
Hum Genet. 1996 Jan;97(1):51-9. doi: 10.1007/BF00218833.
2
Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene.1型酪氨酸血症——延胡索酰乙酰乙酸酶基因中的复杂剪接缺陷和一个错义突变
Hum Genet. 1994 Sep;94(3):235-9. doi: 10.1007/BF00208276.
3
Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.四名I型酪氨酸血症患者的延胡索酰乙酰乙酸水解酶基因突变
Hum Mutat. 1993;2(2):85-93. doi: 10.1002/humu.1380020205.
4
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.小鼠延胡索酰乙酰乙酸水解酶基因中的点突变:人类遗传性1型酪氨酸血症遗传疾病的动物模型。
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5. doi: 10.1073/pnas.98.2.641.
5
Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1.富马酰乙酰乙酸酯酶基因中的新型剪接、错义及无义突变导致1型酪氨酸血症。
Am J Hum Genet. 1994 Oct;55(4):653-8.
6
Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.在五名患有I型遗传性酪氨酸血症的芬兰患者中鉴定出一个终止突变。
Hum Mol Genet. 1994 Jan;3(1):69-72. doi: 10.1093/hmg/3.1.69.
7
Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1.一名患有1型慢性酪氨酸血症的美国儿童,其外显子12剪接突变和W234G错义突变的杂合性。
Hum Mutat. 1995;6(1):66-73. doi: 10.1002/humu.1380060113.
8
Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries.西北欧和地中海国家1型酪氨酸血症患者延胡索酰乙酰乙酸水解酶基因突变谱
Hum Mutat. 1998;12(1):19-26. doi: 10.1002/(SICI)1098-1004(1998)12:1<19::AID-HUMU3>3.0.CO;2-3.
9
Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.I型遗传性酪氨酸血症患者富马酰乙酰乙酸水解酶基因中的六个新突变。
Hum Mutat. 1996;7(4):367-9. doi: 10.1002/(SICI)1098-1004(1996)7:4<367::AID-HUMU14>3.0.CO;2-0.
10
Compound mutations (R237X and L375P) in the fumarylacetoacetate hydrolase gene causing tyrosinemia type I in a Chinese patient.复合突变(R237X 和 L375P)在延胡索酰乙酰乙酸水解酶基因导致中国患者的Ⅰ型酪氨酸血症。
Chin Med J (Engl). 2012 Jun;125(12):2132-6.

引用本文的文献

1
A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.1型酪氨酸血症的新生儿筛查假阴性——需要用琥珀酰丙酮重新评估新生儿筛查
Int J Neonatal Screen. 2023 Dec 4;9(4):66. doi: 10.3390/ijns9040066.
2
The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1).FAH 基因的 c.607G>a 和 c.657delC 复合杂合突变与 1 型遗传性酪氨酸血症(HT1)相关的肾损伤有关。
Mol Genet Genomic Med. 2023 Jan;11(1):e2090. doi: 10.1002/mgg3.2090. Epub 2022 Nov 12.
3
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.

本文引用的文献

1
Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.遗传性I型酪氨酸血症。富马酰乙酰乙酸酶缺陷的自我纠正。
J Clin Invest. 1993 Apr;91(4):1816-21. doi: 10.1172/JCI116393.
2
Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity.人富马酰乙酰乙酸水解酶基因的特征分析及导致酶活性丧失的错义突变的鉴定。
Hum Mol Genet. 1993 Jul;2(7):941-6. doi: 10.1093/hmg/2.7.941.
3
Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
治疗性调控 RNA 剪接在恶性和非恶性疾病中的作用。
Trends Mol Med. 2021 Jul;27(7):643-659. doi: 10.1016/j.molmed.2021.04.005. Epub 2021 May 13.
4
Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.遗传性1型酪氨酸血症中富马酰乙酰乙酸水解酶基因突变的地理和种族分布
JIMD Rep. 2015;19:43-58. doi: 10.1007/8904_2014_363. Epub 2015 Feb 15.
5
Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential.新生儿I型酪氨酸血症筛查:血斑中琥珀酰丙酮测定至关重要的进一步证据
JIMD Rep. 2011;1:107-9. doi: 10.1007/8904_2011_24. Epub 2011 Jun 22.
6
Genomic features defining exonic variants that modulate splicing.定义外显子变体调节剪接的基因组特征。
Genome Biol. 2010;11(2):R20. doi: 10.1186/gb-2010-11-2-r20. Epub 2010 Feb 16.
7
Tyrosinemia type 1 and Angelman syndrome due to paternal uniparental isodisomy 15.1 型酪氨酸血症和 Angelman 综合征源于父源 15 号染色体单亲二体性
J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S349-53. doi: 10.1007/s10545-009-9014-9. Epub 2009 Dec 23.
8
A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation.导致遗传性酪氨酸血症的富马酰乙酰乙酸水解酶基因中的一个错义突变(Q279R)起到剪接突变的作用。
BMC Genet. 2001;2:9. doi: 10.1186/1471-2156-2-9. Epub 2001 Jun 29.
9
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.小鼠延胡索酰乙酰乙酸水解酶基因中的点突变:人类遗传性1型酪氨酸血症遗传疾病的动物模型。
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):641-5. doi: 10.1073/pnas.98.2.641.
10
The human nuclear-encoded acyl carrier subunit (NDUFAB1) of the mitochondrial complex I in human pathology.人类病理学中线粒体复合物I的人类核编码酰基载体亚基(NDUFAB1)
J Inherit Metab Dis. 1999 Apr;22(2):163-73. doi: 10.1023/a:1005402020569.
四名I型酪氨酸血症患者的延胡索酰乙酰乙酸水解酶基因突变
Hum Mutat. 1993;2(2):85-93. doi: 10.1002/humu.1380020205.
4
Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.在五名患有I型遗传性酪氨酸血症的芬兰患者中鉴定出一个终止突变。
Hum Mol Genet. 1994 Jan;3(1):69-72. doi: 10.1093/hmg/3.1.69.
5
Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene.1型酪氨酸血症——延胡索酰乙酰乙酸酶基因中的复杂剪接缺陷和一个错义突变
Hum Genet. 1994 Sep;94(3):235-9. doi: 10.1007/BF00208276.
6
A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.法裔加拿大人遗传性I型酪氨酸血症患者中富马酰乙酰乙酸水解酶基因的单一突变。
N Engl J Med. 1994 Aug 11;331(6):353-7. doi: 10.1056/NEJM199408113310603.
7
Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.两个错义突变导致1型酪氨酸血症,伴有或不伴有免疫反应性延胡索酰乙酰乙酸酶。
Hum Genet. 1994 Jun;93(6):615-9. doi: 10.1007/BF00201558.
8
Identification of a frequent pseudodeficiency mutation in the fumarylacetoacetase gene, with implications for diagnosis of tyrosinemia type I.在富马酰乙酰乙酸酯酶基因中鉴定出一种常见的假缺陷突变,对I型酪氨酸血症的诊断具有重要意义。
Am J Hum Genet. 1994 Dec;55(6):1122-7.
9
Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1.富马酰乙酰乙酸酯酶基因中的新型剪接、错义及无义突变导致1型酪氨酸血症。
Am J Hum Genet. 1994 Oct;55(4):653-8.
10
Self-induced correction of the genetic defect in tyrosinemia type I.I型酪氨酸血症遗传缺陷的自我诱导纠正。
J Clin Invest. 1994 Oct;94(4):1657-61. doi: 10.1172/JCI117509.